← 홈

ADC

1,032개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-6 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,032개
ADCBiologicstaleThe First Affiliated Hospital o…Phase 1

Monomethyl Auristatin E (MMAE, Monomethyl Auristatin E, Monomethyl Auristatin E (MMAE) / autologous neutrophil biological agents)

Unresectable Pancreatic Cancer · Unresectable Pancreatic Cancer

#UnresectablePancreaticCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleAcademic and Community Cancer R…Phase 2

Multi-epitope HER2 Peptide Vaccine TPIV100 (Multi-epitope HER2 Peptide Vaccine TPIV100)

Breast Adenocarcinoma; Stage II Breast Cancer AJCC v6 and v7 · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 ACTIVE
ADCBiologicstalePfizerPhase 2

Mylotarg (Mylotarg)

Leukemia, Myeloid, Acute · Leukemia, Myeloid, Acute

#LeukemiaMyeloidAcute#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 1상태 RECRUITING
ADCBiologicstaleNBE-Therapeutics AGPhase 2

NBE-002 (NBE-002)

Advanced Solid Tumor; Advanced Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 DISCONTINUED
ADCBiologicstaleNEOK Bio, Inc.Phase 1

NEOK001 (NEOK001)

Locally Advanced (Unresectable) or Metastatic Solid Tumors · Locally Advanced (Unresectable) or Metas

#LocallyAdvancedUnresectableorMet#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleNEOK Bio, Inc.Phase 1

NEOK001 RDE (NEOK001 RDE)

Locally Advanced (Unresectable) or Metastatic Solid Tumors · Locally Advanced (Unresectable) or Metas

#LocallyAdvancedUnresectableorMet#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleNEOK Bio, Inc.Phase 1

NEOK002 (NEOK002)

Locally Advanced (Unresectable) or Metastatic Solid Tumors · Locally Advanced (Unresectable) or Metas

#LocallyAdvancedUnresectableorMet#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleNEOK Bio, Inc.Phase 1

NEOK002 RDE (NEOK002 RDE)

Locally Advanced (Unresectable) or Metastatic Solid Tumors · Locally Advanced (Unresectable) or Metas

#LocallyAdvancedUnresectableorMet#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleNovartis PharmaceuticalsPhase 1

NJH395 (NJH395)

NON-breast HER2+ Malignancies · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleNovelty Nobility, Inc.Phase 1

NN3201 (NN3201)

Gastrointestinal Stromal Tumors; Small-cell Lung Cancer · Gastrointestinal Stromal Tumors

#GastrointestinalStromalTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleOncomatryx Biopharma S.L.Phase 1

Nab-paclitaxel + Gemcitabine (Nab-paclitaxel + Gemcitabine)

Pancreatic Adenocarcinoma Metastatic · Pancreatic Adenocarcinoma Metastatic

#PancreaticAdenocarcinomaMetastat#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleXijing HospitalPhase 2

Neratinib Combined with Fulvestrant and Eribulin (Neratinib Combined with Fulvestrant and Eribulin)

Brest Cancer · Brest Cancer

#BrestCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleFox Chase Cancer CenterPhase 1

Neratinib Pill (Neratinib Pill)

Gastric Cancer; Gastrointestinal Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleShengjing HospitalPhase 2

Next-generation Site-specific human epidermal growth factor receptor 2 (HER2, Next-generation Site-specific human epidermal growth factor receptor 2, Next-generation Site-specific human epidermal growth factor receptor 2 (HER2)-targeting Antibody-drug Conjugate (ARX788))

Breast Neoplasms · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleGilead SciencesPreclinical

ADC (Non-Investigational Antibody-Drug Conjugates, Non-Investigational Antibody-Drug Conjugates (ADC))

HER2-negative Breast Cancer; HER2 Negative Breast Carcinoma · HER2

#HER2#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleOBI Pharma, IncPhase 2

OBI-902 (OBI-902)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleOBI Pharma, IncPhase 2

OBI-992 (OBI-992)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleOBI Pharma, IncPhase 2

OBI-999 (OBI-999)

Locally Advanced Solid Tumor · Locally Advanced Solid Tumor

#LocallyAdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 0%임상시험 1상태 DISCONTINUED
ADCBiologicstaleOxford BioTherapeutics LtdPhase 1

OBT076, a CD205-directed antibody-drug conjugate (OBT076, a CD205-directed antibody-drug conjugate)

Solid Tumor · CD20

#CD20#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleOrum Therapeutics USA, Inc.Phase 1

ORM-5029 (ORM-5029)

HER2-positive Breast Cancer; HER-2 Protein Overexpression · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 DISCONTINUED

45 / 52 페이지

← 이전다음 →